NDC 71930-050

Potassium-cit

Potassium-cit

Potassium-cit is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Eywa Pharma Inc. The primary component is Potassium Citrate.

Product ID71930-050_4bbe0717-80c3-468a-aaf2-4f31158d1bd0
NDC71930-050
Product TypeHuman Prescription Drug
Proprietary NamePotassium-cit
Generic NamePotassium-cit
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2021-03-01
Marketing CategoryANDA /
Application NumberANDA214426
Labeler NameEywa Pharma Inc
Substance NamePOTASSIUM CITRATE
Active Ingredient Strength15 meq/1
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 71930-050-12

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-050-12)
Marketing Start Date2021-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Potassium-cit" or generic name "Potassium-cit"

NDCBrand NameGeneric Name
70518-3328Potassium-citpotassium-cit
71930-048Potassium-citPotassium-cit
71930-049Potassium-citpotassium-cit
71930-050Potassium-citPotassium-cit

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.